ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
|
ICER hosted the first annual Comparative Effectiveness Research National Leadership Awards Dinner on Thursday, October 4, 2012 and honored Sean Tunis, MD, MSc, of the Center for Medical Technology Policy and Daniel B. Wolfson, MHSA, of the ABIM Foundation. We are grateful for the support of our Gold Sponors: America's Health Insurance Plans, Blue Cross Blue Shield Association, Blue Cross Blue Shield of Massachusetts, Genzyme, the National Pharmaceutical Council and UnitedHealth Group.
|